Purpose
To compare the efficacy and safety of high-dose vitamin C plus FOLFOX ± bevacizumab versus FOLFOX ± bevacizumab as first-line treatment in patients with metastatic colorectal cancer (mCRC).Patients and methods
Between 2017 and 2019, histologically confirmed patients with mCRC...
